Responses
Scientific Abstracts
Abstracts accepted for publication
Scleroderma, myositis and related syndromes – clinical aspects and treatment
AB0830 Role of anti-IFI16 antibodies and NT-PROBNP as candidate biomarkers in systemic sclerosis
Compose a Response to This Article
Other responses
No responses have been published for this article.